AMERSA

AMERSA

Call Us: (401) 615-4047 | Contact Us AMERSA on Twitter AMERSA on LinkedIn AMERSA on BlueSky

Make a Donation Pay a Past-Due Balance Join Our Mailing List
  • About
    • What is AMERSA
    • Board of Directors
    • Donate to AMERSA
    • Contact Us
  • Membership
    • Get to Know AMERSA
    • Join / Renew
    • Who We Are
    • Member Center
    • Special Interest Groups
    • Career Opportunities
    • Professional & Academic Advancement Opps
  • Conference
    • Annual Conference
    • Conference Sponsorship
    • Conference Exhibitor Information
    • Policy and Procedures for AMERSA Events
    • 2024 Conference Materials
    • Past Conference Resources
  • Journal
    • Journal Home
    • About Us
    • Member Access to Journal
    • Author Instructions and Submission
    • SAj Blog
    • SAj Annual Awards
    • SAj Editorial Scholar Program
  • Advocacy
    • AMERSA Advocacy
    • Position Statements
    • Submit a Position Statement
    • Letters of Support
    • Public Comments
  • Sustainability
    • Initiatives
    • Resources
  • Education
    • AMERSA Podcast Series
    • AMERSA Webinars
    • Core Competencies – AMERSA in the 21st Century
    • Resources
  • Awards
    • AMERSA Awards
    • Current Award Winners
    • Past Award Winners

2022 Oral Presentations

A National Fetal Alcohol Spectrum Disorders (FASDs) Learning Collaborative for Prenatal and Pediatric Healthcare Teams
Alford DP, German JS, Messelt S, Gludt K, Greece J, Bangham C, Harlowe A, Kitten N, Brown S, Hardesty I, Levinson D, Smith VC

Effectiveness of Substance Use Navigation for Emergency Department Patients with Substance Use Disorders; An Implementation Study
Erik S. Anderson, MD, Highland Hospital
Emergency Medicine & Addiction Medicine

A Special K-ase: Exploring recreational ketamine use and associated harms
Maya Appley, MD, MPH with significant contributions from Jessica Gray, MD

Characteristics of Mothers with Substance Addiction that Predict Graduation from the Family Treatment Court
Kathy Barnett, DNS, RN, Assistant Professor of Nursing, Kennesaw State University

Smartphone-based secondary prevention intervention for university students with unhealthy alcohol use: a randomized controlled trial
Nicolas Bertholet, Elodie Schmutz, Joseph Studer, Angéline Adam, Gerhard Gmel, John A Cunningham, Jennifer McNeely, Jean-Bernard Daeppen

Leveraging Community to Improve Addiction Recovery Support for Permanent & Supportive Housing Residents
Nick Christian, MD, MBA; John Moore, MSW
Members of the Wellness Advisory Board

Integrating Contingency Management Into an Academic Outpatient Addiction Clinic for Patients With Cocaine Use Disorder
Nicholaus Christian, MD, MBA; Dana Cavallo, PhD; Stephen Holt, MD, MS

Implementation of ED-Initiated Buprenorphine for Opioid Use Disorder
Gail D’Onofrio MD, MS, Yale University School of Medicine

Low Incidence of Precipitated Withdrawal in ED-initiated Buprenorphine
Gail D’Onofrio MD, MS, Yale University School of Medicine

Process and Outcome Evaluation of Recovery Opioid Overdose Team Plus (ROOT+): A Post-Overdose Community Outreach Program Utilizing Peer Recovery Coaches
Gina Dahlem; Brianna Dobbs; Mary Dwan

Complications in the Era of Fentanyl: A Case of Precipitated Opioid Withdrawal Treated With Ketamine in a Hospitalized Patient
Mariah Evarts, MD; Nicholaus Christian, MD, MBA; Jenna Butner, MD; Melissa Weimer, DO, MCR, DFASAM

A National Study of Correlates of Homelessness and Retention Among Outpatient Medication for Opioid Use Disorder-Seeking Individuals in the United States
Marina Gaeta Gazzola, MD, Iain D. Carmichael, PhD, Nicholaus Christian, MD, Xiaoying Zheng, Lynn M. Madden, PhD, Declan T. Barry, PhD

Rapid Low-Dose Buprenorphine Induction for Hospitalized Patients with Opioid Use Disorder
Amelia Goff, MSN; Eleasa Sokolski, MD; Emily Skogrand, PharmD; Honora Englander, MD 

Accelerating Interdisciplinary Education in Opioid Use Disorder and Harm Reduction: Two Year Results of the AIROH Program
Aaron Greenblatt, MD and Sarah Kattakuzhy, MD, MPH; Britt Gayle, MD, MPH; Meghan Derenoncourt, BA; Danielle Baek, MD; Aditi Ringwala, MD; Elana Rosenthal, MD

“If you’re strung out and female, they will take advantage of you”: A qualitative study exploring drug use and addiction service experiences among women in Boston and San Francisco
Miriam TH Harris, MD, MSc Boston University School of Medicine
Collaborators: Jordana Laks,  Ariel Maschke, Audrey M Lambert, Jennifer Jain, Sarah M Bagley, Alexander Y Walley, Emily Hurstak, John Farley, Philip O Coffin, Sarah G Keller, Christine M Gunn

A Nation-Wide Emergency Department Quality Initiative to Improve Care of Patients with Opioid Use Disorder
Kathryn Hawk MD, MHS

Xylazine in the post-mortem toxicology of Maryland opioid overdose decedents (2020)
Renee M. Johnson, PhD, MPH
Rachel Alinsky, MD MPH; Masoumeh Amin-Esmaeili, MD, MPH; Kelly Dunn; Renee M. Johnson, PhD, MPH

Complex Care Utilization for a Patient in Novel Managed Alcohol Program (MAP)
Megan Kennel, RN, Elizabeth Abbs, MD, Devora Keller, MD

Characteristics of post-overdose outreach programs and municipal-level overdose in Massachusetts
Simeon D. Kimmel, MD, MA, Ziming Xuan, ScD, SM, Shapei Yan, MPH,Audrey M. Lambert, MPH, Scott W. Formica, PhD,Traci C. Green, PhD, MSc, Jennifer J. Carroll, PhD, MPH, Sarah M. Bagley, MD, MSc, David Rosenbloom, PhD,Leo Beletsky, JD, MPH,Alexander Y. Walley, MD, MSc

Utilization of Medication for Opioid Use Disorder Treatment During Hospitalization at Six New York City Public Hospitals with an Addiction Consultation Service
Carla King, MPH, PhD Student

Bridge Clinic Management of Benzodiazepine Use Disorder: Intensive Outpatient Benzodiazepine Tapers
Jordana Laks, MD MPH, Section of General Internal Medicine, Boston University
Collaborators: Theresa W. Kim MD, James Evans RN, Jessica Kehoe NP, Morgan Younkin MD, MPH, Jessica L. Taylor MD

Adapting a Virtual Urgent Care Model to Provide Low-Threshold Buprenorphine Transitional Care: Feasibility and Early Outcomes
Maggie Lowenstein, MD, MPhil, MSHP

Implementation of Mirtazapine for Methamphetamine Use Disorder in CA Bridge Emergency Departments: A Quality Improvement Project
Amy Liang, Erik Anderson, Arianna Campbell, Andrew Herring

Medical Student Experiences and Perceptions of Substance Use Among Healthcare Workers
Tabitha E. Moses MS, Taylor Harrison, Eva Waineo MD, Mark K. Greenwald PhD

Missed opportunities following overdose among people who use substances in Boston, MA
Alykhan Nurani, MS; Ranjani Paradise, PhD; Jeff Desmarais, MA; Andrés Hoyos-Céspedes, MPH, CPH; Shannon O’Malley, MS; Jaylen Clarke, MSc; Angela R. Bazzi, PhD, MPH; Sunday Taylor, PhD; Dan Dooley; Simeon D. Kimmel, MD, MA

Barriers and Facilitators to Collaboration Between Community-Based Medication for Opioid Use Disorder Providers & Drug Courts
Ekaterina Pivovarova, Ph.D.,  Faye Taxman, Ph.D., David Smelson, Psy.D., Alexandra Boland, B.A., Stephenie Lemon, Ph.D., & Peter Friedmann, M.D., MPH

A Prescription Drug Illegal Marketing Case: “Dead Baby” Messaging, a Billion-Dollar “Product Hop” & the Buprenorphine Public Health Campaign That Wasn’t
Gail Groves Scott, MPH, Health Policy Network, LLC,  Doctoral student in Health Policy

Addressing Clinician Stigma Toward Perinatal Substance Use Through Art: Proof of Concept and Initial Feasibility of ArtSpective™
Clayton J. Shuman, PhD, MSN, RN, University of Michigan School of Nursing

SHIELD training increases first responders’
intention to refer overdose survivors to harm reduction services

Saad T. Siddiqui, Anna La Manna, Elizabeth Connors, Ryan Smith, Claire A. Wood, Katherine Brown, Jeremiah Goulka Leo Beletsky, Rachel P. Winograd

Self Reported Xylazine Exposure and Experiences: A Mixed Methods Study of Reddit Users
Tony Spadaro, MD MPH, Hospital of the University of Pennsylvania, Dept of Emergency Medicine

Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers
Thomas J. Stopka, PhD, MHS, Rebecca Rottapel, MPH, MS, Warren J. Ferguson, MD, Ekaterina Pivovarova, PhD, Lizbeth Del Toro-Mejias, MS, Peter D. Friedmann, MD, MPH, and Elizabeth A. Evans, PhD, MA

Suicide-related care among individuals who have experienced an opioid-involved overdose
Bobbi Jo H. Yarborough, Scott P. Stumbo, Alison Firemark, Brian K. Ahmedani, Lisa Matero, Deborah S. Ling Grant, Joslyn Westphal, Stefan Massimino, Matthew Stefanko, Jessica Hulsey Nickel, Douglas Hulst, Mary Jean Coleman, Clayton P.A. Carson, Marcia Lee Taylor, Cambria Bruschke, Jon Swanson, Anna Leonard, Karen J. Coleman

Question: “What are we doing when we identify opioid use disorder?”
Response:
1. “__________”
2. ED-initiated buprenorphine
3. SUD Committee

SUD Committee

How Healthcare Utilization is Associated with Medications for Alcohol Use Disorder (MAUD) After Hospitalization
Kumar Felipe Vasudevan, MD, Director of Addiction Consult Services – UCLA Ronald Reagan, Graduate of NYU Addiction Medicine Fellowship

What about nights, weekends, and wait times? Adding an on-demand mobile telemedicine component to a community-based, post-overdose peer support outreach program
Rachel P. Winograd. PhD, Katherine Brown, LSCW, Zach Budesa, PhD, Bradley Wing, PhD, Chelsey Wilks, PhD, Devin Banks, PhD, Ryan W. Carpenter, PhD, Wendy Orson., Christie Becker-Markovich, Meghan Zychinski,, Rithvik Kondai, Sarfaraz Jasdanwala, MD

More Money? Mo-FTS Findings from a pilot Fentanyl Test Strip distribution program using Missouri’s substance use workforce
Rachel Winograd, PhD., Rithvik Kondai, Elizabeth Connors, MSW, LCSW., Katherine Brown, MPA, MSW, LCSW, Aaron Ruiz, CPS, Christine Smith

Copyright © 2025
Site by: web360